z-logo
open-access-imgOpen Access
How we treated a kidney transplant recipient who was receiving sirolimus during the SARS-CoV-2 pandemic? primum non nocere”
Author(s) -
Hamad Dheir,
Didar Şenocak,
Savaş SİPAHİ,
Yasemin Gündüz,
Selçuk Yaylacı,
Necattin Fırat,
Ahmed Bilal Genç,
Mehmet Köroğlu,
Oğuz Karabay
Publication year - 2022
Publication title -
sakarya medical journal
Language(s) - English
Resource type - Journals
ISSN - 2146-409X
DOI - 10.31832/smj.783277
Subject(s) - medicine , azithromycin , hydroxychloroquine , sirolimus , kidney transplantation , prednisolone , primum non nocere , everolimus , transplantation , population , surgery , covid-19 , antibiotics , disease , environmental health , infectious disease (medical specialty) , microbiology and biotechnology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom